These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 16776693
1. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study. Silberstein SD, Göbel H, Jensen R, Elkind AH, Degryse R, Walcott JM, Turkel C. Cephalalgia; 2006 Jul; 26(7):790-800. PubMed ID: 16776693 [Abstract] [Full Text] [Related]
2. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study. Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group. Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098 [Abstract] [Full Text] [Related]
3. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R, Schreiber C. Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [Abstract] [Full Text] [Related]
4. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group. Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567 [Abstract] [Full Text] [Related]
5. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache. Mathew NT, Kailasam J, Meadors L. Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356 [Abstract] [Full Text] [Related]
6. A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches. Relja M, Poole AC, Schoenen J, Pascual J, Lei X, Thompson C, European BoNTA Headache Study Group. Cephalalgia; 2007 Jun; 27(6):492-503. PubMed ID: 17428299 [Abstract] [Full Text] [Related]
7. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine. Saper JR, Mathew NT, Loder EW, DeGryse R, VanDenburgh AM, BoNTA-009 Study Group. Pain Med; 2007 Sep; 8(6):478-85. PubMed ID: 17716321 [Abstract] [Full Text] [Related]
8. Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine. Blumenfeld AM, Schim JD, Chippendale TJ. Headache; 2008 Feb; 48(2):210-20. PubMed ID: 18047502 [Abstract] [Full Text] [Related]
9. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study. Harden RN, Cottrill J, Gagnon CM, Smitherman TA, Weinland SR, Tann B, Joseph P, Lee TS, Houle TT. Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577 [Abstract] [Full Text] [Related]
10. Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study. Schulte-Mattler WJ, Krack P, BoNTTH Study Group. Pain; 2004 May; 109(1-2):110-4. PubMed ID: 15082132 [Abstract] [Full Text] [Related]
11. Botulinum toxin type A for the treatment of nummular headache: four case studies. Mathew NT, Kailasam J, Meadors L. Headache; 2008 Mar; 48(3):442-7. PubMed ID: 18028377 [Abstract] [Full Text] [Related]
12. Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Padberg M, de Bruijn SF, de Haan RJ, Tavy DL. Cephalalgia; 2004 Aug; 24(8):675-80. PubMed ID: 15265057 [Abstract] [Full Text] [Related]
13. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial. LaForce C, Man CY, Henderson FW, McElhaney JE, Hampel FC, Bettis R, Kudule L, Harris J, Yates P, Tisdale M, Webster A. Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541 [Abstract] [Full Text] [Related]
14. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. Lowe NJ, Glaser DA, Eadie N, Daggett S, Kowalski JW, Lai PY, North American Botox in Primary Axillary Hyperhidrosis Clinical Study Group. J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417 [Abstract] [Full Text] [Related]
15. Botulinum toxin A in the prophylactic treatment of migraine--a randomized, double-blind, placebo-controlled study. Evers S, Vollmer-Haase J, Schwaag S, Rahmann A, Husstedt IW, Frese A. Cephalalgia; 2004 Oct; 24(10):838-43. PubMed ID: 15377314 [Abstract] [Full Text] [Related]
16. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study. Göbel H, Heinze A, Reichel G, Hefter H, Benecke R, Dysport myofascial pain study group. Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294 [Abstract] [Full Text] [Related]
17. A randomized, double-blind, placebo-controlled study of venlafaxine XR in out-patients with tension-type headache. Zissis NP, Harmoussi S, Vlaikidis N, Mitsikostas D, Thomaidis T, Georgiadis G, Karageorgiou K. Cephalalgia; 2007 Apr; 27(4):315-24. PubMed ID: 17346304 [Abstract] [Full Text] [Related]
18. Botulinum toxin in tension-type headache. Relja M, Telarović S. J Neurol; 2004 Feb; 251 Suppl 1():I12-4. PubMed ID: 14991337 [Abstract] [Full Text] [Related]
19. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials. Shuhendler AJ, Lee S, Siu M, Ondovcik S, Lam K, Alabdullatif A, Zhang X, Machado M, Einarson TR. Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252 [Abstract] [Full Text] [Related]
20. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C, BOTOX CDH Study Group. Headache; 2005 Apr; 45(4):293-307. PubMed ID: 15836565 [Abstract] [Full Text] [Related] Page: [Next] [New Search]